Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the writing committee of the American society for apheresis: the …

J Schwartz, A Padmanabhan, N Aqui… - Journal of clinical …, 2016 - Wiley Online Library
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special
Issue Writing Committee is charged with reviewing, updating, and categorizing indications …

UK consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T‐cell lymphoma and chronic graft‐versus‐host disease

JJ Scarisbrick, P Taylor, U Holtick… - British Journal of …, 2008 - academic.oup.com
Extracorporeal photopheresis (ECP) has been used for over 30 years in the treatment of
erythrodermic cutaneous T‐cell lymphoma (CTCL) and over 20 years for chronic graft …

Guidelines on the use of therapeutic apheresis in clinical practice—evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …

J Schwartz, JL Winters, A Padmanabhan… - Journal of clinical …, 2013 - Wiley Online Library
The American Society for Apheresis (ASFA) JCA Special Issue Writing Committee is
charged with reviewing, updating and categorizating indications for therapeutic apheresis …

Guidelines on the use of therapeutic apheresis in clinical practice—evidence‐based approach from the Apheresis Applications Committee of the American Society for …

ZM Szczepiorkowski, JL Winters… - Journal of clinical …, 2010 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Apheresis Applications Committee is
charged with a review and categorization of indications for therapeutic apheresis. Beginning …

Guidelines on the use of extracorporeal photopheresis

R Knobler, G Berlin, P Calzavara‐Pinton… - Journal of the …, 2014 - Wiley Online Library
Background After the first investigational study on the use of extracorporeal photopheresis
for the treatment of cutaneous T‐cell lymphoma was published in 1983 with its subsequent …

[HTML][HTML] Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease

D Wolff, M Schleuning, S von Harsdorf, U Bacher… - Biology of Blood and …, 2011 - Elsevier
Steroid refractory chronic graft-versus-host disease (cGVHD) is associated with a significant
morbidity and mortality. Although first-line treatment of cGVHD is based on controlled trials …

European dermatology forum–updated guidelines on the use of extracorporeal photopheresis 2020–part 1

R Knobler, P Arenberger, A Arun… - Journal of the …, 2020 - Wiley Online Library
Background Following the first investigational study on the use of extracorporeal
photopheresis for the treatment of cutaneous T‐cell lymphoma published in 1983, this …

The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus …

A Alfred, PC Taylor, F Dignan… - British journal of …, 2017 - Wiley Online Library
Extracorporeal photopheresis (ECP) has been used for over 35 years in the treatment of
erythrodermic cutaneous T‐cell lymphoma (CTCL) and over 20 years for chronic and acute …

Diagnosis and management of chronic graft‐versus‐host disease

FL Dignan, P Amrolia, A Clark, J Cornish… - British journal of …, 2012 - Wiley Online Library
A joint working group established by the Haemato‐oncology subgroup of the B ritish C
ommittee for S tandards in H aematology (BCSH) and the B ritish S ociety for B one M arrow …

Extracorporeal photopheresis for the treatment of acute and chronic graft‐versus‐host disease in adults and children: best practice recommendations from an I talian S …

L Pierelli, P Perseghin, M Marchetti, C Messina… - …, 2013 - Wiley Online Library
Background Extracorporeal photopheresis (ECP) is an effective treatment for both acute and
chronic graft‐versus‐host disease (GVHD) in children and adults. Despite the large use of …